Lourdes Hontecillas-Prieto

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Histone Deacetylase

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

International journal of molecular sciences

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel José García-Domínguez, Soledad Lopez-Enriquez, Gonzalo Alba, Carmen Garnacho, Carlos Jiménez-Cortegana, Rocío Flores-Campos, Luis de la Cruz-Merino, Nabil Hajji, Víctor Sánchez-Margalet, Lourdes Hontecillas-Prieto
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. International journal of molecular sciences 25 (2) (2024)
Daniel José García-Domínguez, Soledad Lopez-Enriquez, Gonzalo Alba, Carmen Garnacho, Carlos Jiménez-Cortegana, Rocío Flores-Campos, Luis de la Cruz-Merino, Nabil Hajji, Víctor Sánchez-Margalet, Lourdes Hontecillas-Prieto
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. International journal of molecular sciences 25 (2) (2024)
Daniel José García-Domínguez, Soledad Lopez-Enriquez, Gonzalo Alba, Carmen Garnacho, Carlos Jiménez-Cortegana, Rocío Flores-Campos, Luis de la Cruz-Merino, Nabil Hajji, Víctor Sánchez-Margalet, Lourdes Hontecillas-Prieto
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. International journal of molecular sciences 25 (2) (2024)
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, Carmen Garnacho, Luis de la Cruz-Merino, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International journal of molecular sciences 24 (6) (2023)
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, Carmen Garnacho, Luis de la Cruz-Merino, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International journal of molecular sciences 24 (6) (2023)
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, Carmen Garnacho, Luis de la Cruz-Merino, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International journal of molecular sciences 24 (6) (2023)
Daniel José García-Domínguez, Nabil Hajji, Roser López-Alemany, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Francisco J Morón Civanto, Santiago Rello-Varona, Eduardo Andrés León, Adrián Benito, Hector C Keun, Jaume Mora, Òscar Martínez Tirado, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene 41 (18) (2022)
Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà Padró, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez Carvajal, Jorge Labrador-Gomez, María Guirado-Risueño, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Espejo-García, Isabel Fernández-Román, Mariano Provencio Pulla, Margarita Sánchez-Beato, Marta Navarro, Marylène Lejeune, Tomás Álvaro-Naranjo, Maria Casanova-Espinosa, Víctor Sánchez-Margalet, Antonio Rueda-Domínguez, Luis de la Cruz Merino
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Carlos Jiménez-Cortegana, Lourdes Hontecillas-Prieto, Daniel José García-Domínguez, Fernando Zapata, Natalia Palazón-Carrión, María L Sánchez-León, Malika Tami, Antonio Pérez-Pérez, Flora Sánchez-Jiménez, Teresa Vilariño-García, Luis de la Cruz Merino, Víctor Sánchez-Margalet
Obesity and Risk for Lymphoma: Possible Role of Leptin. International journal of molecular sciences 23 (24) (2022)
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet, Luis de la Cruz Merino, Jaume Catala-Mora, Enrique de Álava, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers 14 (21) (2022)
Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Natalia Palazón-Carrión, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet, Luis de la Cruz Merino
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics. Cancers 14 (6) (2022)
Carlos Jiménez-Cortegana, Lourdes Hontecillas-Prieto, Daniel José García-Domínguez, Fernando Zapata, Natalia Palazón-Carrión, María L Sánchez-León, Malika Tami, Antonio Pérez-Pérez, Flora Sánchez-Jiménez, Teresa Vilariño-García, Luis de la Cruz Merino, Víctor Sánchez-Margalet
Obesity and Risk for Lymphoma: Possible Role of Leptin. International journal of molecular sciences 23 (24) (2022)
Carlos Jiménez-Cortegana, Lourdes Hontecillas-Prieto, Daniel José García-Domínguez, Fernando Zapata, Natalia Palazón-Carrión, María L Sánchez-León, Malika Tami, Antonio Pérez-Pérez, Flora Sánchez-Jiménez, Teresa Vilariño-García, Luis de la Cruz Merino, Víctor Sánchez-Margalet
Obesity and Risk for Lymphoma: Possible Role of Leptin. International journal of molecular sciences 23 (24) (2022)
Daniel José García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Rocío M de Pablos, Ana M Espinosa-Oliva, Eduardo Andrés León, Laura Carmen Terrón-Camero, Rocío Flores-Campos, Guillem Pascual-Pasto, María José Robles, Isidro Machado, Antonio Llombart-Bosch, Giovanna Magagnoli, Katia Scotlandi, Angel Montero Carcaboso, Jaume Catala-Mora, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma. Oncogene 40 (39) (2021)
Silvia Garcia-Monclús, Roser López-Alemany, Olga Almacellas-Rabaiget, David Herrero-Martín, Juan Huertas-Martinez, Laura Lagares-Tena, Piedad Alba-Pavón, Lourdes Hontecillas-Prieto, Jaume Mora, Enrique de Álava, Santiago Rello-Varona, Paloma H Giangrande, Òscar Martínez Tirado
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. International journal of cancer 143 (5) (2018)